Supernus Pharmaceuticals reported $374.79M in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Adamas Pharmaceuticals ADMS:US 129.04M 671K
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Ani Pharmaceuticals ANIP:US $ 201.99M 2.72M
Aphria Inc APH:CN C$ 928.67M 381.15M
Aurora Cannabis Inc ACB:CN 406.78M 7.23M
Bristol Myers Squibb BMY:US $ 44742M 416M
Canopy Growth Corp WEED:CN C$ 1.53B 164.21M
Corcept Therapeutics CORT:US $ 0M 0M
Eisai 4523:JP Y 89912M 2771M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Endo International Ordinary Shares ENDP:US $ 8300.6M 3.52M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Horizon Pharma HZNP:US $ 2573.86M 2.58M
JAZZ PHA JAZZ:US $ 6285.05M 459.25M
Lannett LCI:US $ 596.98M 6.29M
Marinus Pharmaceuticals MRNS:US $ 40.58M 29.61M
Pacira Pharmaceuticals PCRX:US $ 481.9M 6.51M
Perrigo Ordinary Shares PRGO:US $ 3550.3M 5.6M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Supernus Pharmaceuticals SUPN:US $ 374.79M 4.4M
Teva Pharmaceutical Industries TEVA:US $ 23746M 1386M
United Therapeutics UTHR:US $ 800M 0M
Xeris Pharmaceuticals Inc XERS:US $ 87.71M 235K